Actively Recruiting
CDH1-associated Blepharocheilodontic Syndrome Registry
Led by Ohio State University · Updated on 2025-08-21
100
Participants Needed
1
Research Sites
758 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
CONDITIONS
Official Title
CDH1-associated Blepharocheilodontic Syndrome Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A documented pathogenic, likely pathogenic or a variant of uncertain significance in the CDH1 gene
- Clinical features that are diagnostic for, or suggestive of, BCDS such as cleft lip and/or palate, eyelid anomalies, dental abnormalities, webbed toes, imperforate anus, etc
You will not qualify if you...
- Non-English-speaking individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Ohio State University
Columbus, Ohio, United States, 43221
Actively Recruiting
Research Team
M
Maegan E Roberts, MS
CONTACT
P
Peter P Stanich, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here